PA
IDXX icon

PFG Advisors’s Idexx Laboratories IDXX Stock Holding History

PFG Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
5,172
+92
+2% +$51.6K 0.14% 181
2026
Q1 		$2.85M Buy
5,080
+28
+0.6% +$18K 0.14% 184
2025
Q4 		$3.42M Sell
5,052
-6,980
-58% -$4.75M 0.17% 146
2025
Q3 		$7.69M Buy
12,032
+461
+4% +$280K 0.31% 77
2025
Q2 		$6.21M Buy
11,571
+1,196
+12% +$572K 0.29% 71
2025
Q1 		$4.36M Buy
10,375
+2,910
+39% +$1.26M 0.24% 105
2024
Q4 		$3.09M Buy
7,465
+50
+0.7% +$21.9K 0.19% 129
2024
Q3 		$3.75M Sell
7,415
-658
-8% -$320K 0.24% 101
2024
Q2 		$3.93M Sell
8,073
-41
-0.5% -$20.6K 0.27% 90
2024
Q1 		$4.38M Sell
8,114
-961
-11% -$525K 0.32% 71
2023
Q4 		$5.04M Sell
9,075
-410
-4% -$192K 0.41% 60
2023
Q3 		$4.15M Sell
9,485
-86
-0.9% -$42.9K 0.37% 67
2023
Q2 		$4.81M Buy
9,571
+115
+1% +$55.1K 0.37% 67
2023
Q1 		$4.73M Sell
9,456
-128
-1% -$61.3K 0.4% 59
2022
Q4 		$3.91M Buy
9,584
+661
+7% +$257K 0.38% 59
2022
Q3 		$2.91M Buy
8,923
+35
+0.4% +$12.9K 0.33% 70
2022
Q2 		$3.12M Sell
8,888
-502
-5% -$205K 0.35% 58
2022
Q1 		$5.14M Buy
9,390
+964
+11% +$507K 0.51% 31
2021
Q4 		$5.55M Buy
8,426
+147
+2% +$92.3K 0.55% 34
2021
Q3 		$5.15M Sell
8,279
-542
-6% -$364K 0.57% 31
2021
Q2 		$5.57M Buy
8,821
+364
+4% +$201K 0.64% 27
2021
Q1 		$4.14M Buy
8,457
+377
+5% +$189K 0.53% 40
2020
Q4 		$4.04M Sell
8,080
-190
-2% -$85K 0.68% 31
2020
Q3 		$3.19M Buy
8,270
+120
+1% +$44.4K 0.61% 39
2020
Q2 		$2.76M Sell
8,150
-315
-4% -$91.2K 0.62% 38
2020
Q1 		$2.26M Sell
8,465
-309
-4% -$80.6K 0.61% 42
2019
Q4 		$2.38M Buy
8,774
+492
+6% +$130K 0.58% 45
2019
Q3 		$2.25M Buy
8,282
+334
+4% +$92.9K 0.62% 40
2019
Q2 		$2.26M Sell
7,948
-5
-0.1% -$1.23K 0.61% 39
2019
Q1 		$1.84M Sell
7,953
-365
-4% -$75.3K 0.56% 41
2018
Q4 		$1.74M Buy
+8,318
New +$1.71M 0.55% 47

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

PFG Advisors's IDXX Position: Q2 2026 in Review

PFG Advisors increased its Idexx Laboratories (IDXX) stake by 1.8% in Q2 2026, buying an estimated $51.6K and bringing the position to 5,172 shares worth $2.72M. The position accounts for 0.14% of the portfolio, ranked #181.

PFG Advisors first reported a position in IDXX in Q4 2018 and has held it in 31 quarters since. The position peaked at $7.69M in Q3 2025. 408 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • PFG Advisors held 5,172 shares of Idexx Laboratories worth $2.72M as of Q2 2026.
  • PFG Advisors bought 92 Idexx Laboratories shares in Q2 2026, an estimated $51.6K.
  • Idexx Laboratories made up 0.14% of PFG Advisors's portfolio in Q2 2026, its #181 holding.
  • PFG Advisors first reported a position in Idexx Laboratories in Q4 2018 and has held it in 31 quarters since.
  • PFG Advisors's Idexx Laboratories position peaked at $7.69M in Q3 2025.
  • 408 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.